Comparative toxicity and tissue distribution of antimony potassium tartrate in rats and mice dosed by drinking water or intraperitoneal injection

AMA Department of Drugs and the American Society for Clinical Pharmacology and Therapeutics. 1983.AMA Drug Evaluations, 5th ed., 1833–1844. Philadelphia: W.B. Saunders.

Asada M., 1963, Castroenterology, 44, 578, 10.1016/S0016-5085(63)80026-8

Bergmeyer H. U., 1980, Clin. Chim. Acta, 105, 147, 10.1016/0009-8981(80)90105-9

Bergmeyer H. V., 1978, Clin. Chem., 24, 58, 10.1093/clinchem/24.1.58

Bradley W. R., 1941, Ind. Med., 10, 15

Bueding E., 1968, Mode of Action of Antiparasitic Drugs, 1, 81

Chin B. H., 1978, Toxicol. Pathol., 6, 14, 10.1177/019262337800600403

Davies, T. A. L. 1973. “The health of workers engaged in antimony oxide manufacture”. London: Department of Employment, Employment Medical Advisory Service.

Dunn O. J., 1964, Technometrics, 6, 241, 10.1080/00401706.1964.10490181

Dunnett C. W., 1955, J. Am. Stat. Assoc., 50, 1096, 10.1080/01621459.1955.10501294

El‐Aaser A. A., 1979, Eur. J. Cancer, 15, 573, 10.1016/0014-2964(79)90095-1

Fairhall, L. T. 1957.Industrial Toxicology, 2nd ed., 14–17. Baltimore: Williams & Wilkens.

Fairhall L. T., 1947, Public Health Rep. Suppl., 195

Franz G., 1937, Arch. Exp. Pathol. Pharmakol., 186, 661, 10.1007/BF01865163

Fairhall L. T., 1947, Public Health Rep. Suppl., 195

Gay R. J., 1968, Clin. Chem., 14, 740, 10.1093/clinchem/14.8.740

Gilman, A. G., Rall, T. W., Nies, A. S. and Taylor, P. 1990.The Pharmacological Basis of Therapeutics, 8th ed., 959–960. New York: Pergamon Press.

Hausamen T. U., 1967, Clin. Chim. Acta, 15, 241, 10.1016/0009-8981(67)90060-5

Henry, R. J. 1974.Clinical Chemistry: Principles and Techniques, 1149–1154. New York: Harper and Row.

Henry R. J., 1960, Am. J. Clin. Pathol., 34, 381, 10.1093/ajcp/34.4.326

Hoover, J. E., ed. 1975.Remington's Pharmaceutical Sciences, 15th ed., 1173Easton, Pa.: Mack.

Kanisawa M., 1969, Cancer Res., 29, 892

Kaplan, L. A. and Pesce, A. J. 1984.Clinical Chemistry Theory, Analysis and Correlation, 500–502. St. Louis, Mo.: C. V. Mosby.

Kelada F. S., 1972, Metabolism, 21, 1105, 10.1016/0026-0495(72)90105-9

Lockwood T. D., 1979, Toxicol. Appl. Pharmacol., 49, 326

Lucia S. P., 1941, Ind. Med., 10, 15

Maruhn D., 1976, Clin. Chem., 22, 1567, 10.1093/clinchem/22.10.1567

Meneghetti E., 1941, Ind. Med., 10, 15

Morrissey R. E., 1988, Fundam. Appl. Toxicol., 11, 343, 10.1016/0272-0590(88)90159-5

Oelkers H. A., 1947, Public Health Rep. Suppl., 195

Otto G. F., 1950, Am. J. Hyg., 51, 370

Pribyl E., 1947, Public Health Rep. Suppl., 195

Schroeder H. A., 1968, J. Nutr., 95, 95, 10.1093/jn/95.1.95

Schroeder H. A., 1970, J. Nutr., 100, 59, 10.1093/jn/100.1.59

1969, Aertzyl. labor, 15, 34

Shirley E., 1977, Biometrics, 33, 386, 10.2307/2529789

Szasz G., 1967, Clin. Chem., 22, 650, 10.1093/clinchem/22.5.650

Szasz G., 1976, Clin. Chem., 22, 2051, 10.1093/clinchem/22.12.2051

Szasz G., 1974, Z. Klin. Chem. Klin. Biochem., 12, 288

Szaz H. J., 1967, Pharmacol. Rev., 18, 871

Van Esveld L. W., 1947, Public Health Rep. Suppl., 195

Venugopal, B. and Luckey, T D., eds. 1978.Metal Toxicity in Mammals, vol. 2, 213–216. New York: Plenum Press.

Wacker W. E. C., 1956, N. Engl. J. Med., 255, 449, 10.1056/NEJM195609062551001

Wahlenfeld A. W., 1972, Scand. J. Clin. Lab. Invest. Suppl., 29, 11

Watt, W. D. 1983. “Chronic inhalation toxicity of antimony trioxide, validation of the TLV”. Detroit, Mich: Wayne State University. Ph.D. thesis

Weitz A., 1965, Bull. WHO, 33, 137

Wieland M., 1947, Public Health Rep. Suppl., 195

Wiesner I. S., 1965, Am. J. Dig. Dis., 10, 147, 10.1007/BF02236665

Williams D. A., 1986, Biometrics, 42, 183, 10.2307/2531254

Zalups R. K., 1987, Virchows Arch. B, 53, 336, 10.1007/BF02890261